FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections
Two Japanese drugmakers and another in India were hit with Form 483s from the FDA following inspections that uncovered issues ranging from a lack of […]
Skip to content
You May Also Like:
Study finds association nights heart rate and later health problems
Sleep HRV as Early Predictor of Health Risks: A New Study A groundbreaking study from the University Hospital of Bern suggests that monitoring heart rate […]
Blood sugar control brain boost GLP1 drugs tied to less migraine pain
Diabetes Drug Shows Promise in Reducing Migraine Frequency Exciting news for migraine sufferers! A recent study presented at the European Academy of Neurology (EAN) Congress […]
Targeting Fusion Protein Shows Great Leukemia Outcome
Promising New Combination Therapy Identified for Challenging Diseases Researchers at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute have announced a significant breakthrough in […]
One psilocybin dose aids cancer sufferers fight depression
Hope for Cancer Patients: Psilocybin Therapy Shows Long-Term Depression Relief Groundbreaking research offers renewed hope for cancer patients battling depression. A single session of psilocybin-assisted […]
Use GLP1s First to Halt Heart Ailments ACC Suggests
American College of Cardiology Recommends Broader Use of Weight-Loss Drugs for Heart Health The American College of Cardiology (ACC) suggests that a significant number of […]
Stool transplant promising as initial therapy for C difficile disease
Fecal Transplant: A Powerful Alternative to Antibiotics for Severe Diarrhea A groundbreaking study has revealed that fecal microbiota transplantation (FMT), also known as a fecal […]